rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-4-23
|
pubmed:abstractText |
Hepatitis C virus (HCV) infects 4 million people in the USA, with a prevalence of 1.4%. The seropositivity rate among potential lung transplant candidates is 1.9%, yet little information is available regarding outcomes of lung transplantation in HCV-positive lung transplant recipients. Our study reports outcomes of lung transplantation in HCV-positive recipients and compares them to HCV-negative controls.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1557-3117
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
466-71
|
pubmed:meshHeading |
pubmed-meshheading:17449415-Adult,
pubmed-meshheading:17449415-Cause of Death,
pubmed-meshheading:17449415-Cohort Studies,
pubmed-meshheading:17449415-Female,
pubmed-meshheading:17449415-Graft Rejection,
pubmed-meshheading:17449415-Graft Survival,
pubmed-meshheading:17449415-Hepatitis C, Chronic,
pubmed-meshheading:17449415-Humans,
pubmed-meshheading:17449415-Liver Function Tests,
pubmed-meshheading:17449415-Lung Transplantation,
pubmed-meshheading:17449415-Male,
pubmed-meshheading:17449415-Middle Aged,
pubmed-meshheading:17449415-Probability,
pubmed-meshheading:17449415-Reference Values,
pubmed-meshheading:17449415-Retrospective Studies,
pubmed-meshheading:17449415-Risk Assessment,
pubmed-meshheading:17449415-Severity of Illness Index,
pubmed-meshheading:17449415-Survival Rate,
pubmed-meshheading:17449415-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Outcomes after lung transplantation in patients with chronic hepatitis C virus infection.
|
pubmed:affiliation |
Department of Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|